Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 21 results:
Author Title [ Type(Desc)] Year
Filters: Author is Huerta, C.  [Clear All Filters]
Journal Article
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
A. Ruigomez, Brauer, R., Rodriguez, L. A., Huerta, C., Requena, G., Gil, M., de Abajo, F., Downey, G., Bate, A., Tepie, M. F., de Groot, M., Schlienger, R., Reynolds, R., and Klungel, O., Ascertainment of acute liver injury in two European primary care databases, Eur J Clin Pharmacol, vol. 70, pp. 1227-35, 2014.
C. Huerta, Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., de Groot, M. C., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia-Rodriguez, L. A., Johansson, S., de Vries, F., Schlienger, R. G., Reynolds, R. F., Klungel, O. H., and de Abajo, F. J., Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
G. Requena, Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., de Groot, M. C., Bate, A., Johansson, S., Schlienger, R., Reynolds, R., Klungel, O. H., and de Abajo, F. J., Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
C. Huerta, Rivero, E., and Rodriguez, L. A., Incidence and risk factors for psoriasis in the general population, Arch Dermatol, vol. 143, pp. 1559-65, 2007.
L. Ibanez, Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., E. Merino, M., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., van den Ham, R., Souverein, P., Klungel, O., and Gardarsdottir, H., Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study, Br J Clin Pharmacol, 2019.
C. Huerta and Rodriguez, L. A., Incidence of ocular melanoma in the general population and in glaucoma patients, J Epidemiol Community Health, vol. 55, pp. 338-9, 2001.
D. Gaist, Rodriguez, L. A., Huerta, C., Hallas, J., and Sindrup, S. H., Lipid-lowering drugs and risk of myopathy: a population-based follow-up study, Epidemiology, vol. 12, pp. 565-9, 2001.
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population, Heart, vol. 92, pp. 1610-5, 2006.
J. Erviti, Alonso, A., Oliva, B., Gorricho, J., Lopez, A., Timoner, J., Huerta, C., Gil, M., and de Abajo, F., Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study, BMJ Open, vol. 3, 2013.
S. F. Lanes, Rodriguez, L. A. Garcia, and Huerta, C., Respiratory medications and risk of asthma death, Thorax, vol. 57, pp. 683-6, 2002.
C. Huerta, Lanes, S. F., and Rodriguez, L. A. Garcia, Respiratory medications and the risk of cardiac arrhythmias, Epidemiology, vol. 16, pp. 360-6, 2005.
C. Huerta, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom, Arch Intern Med, vol. 167, pp. 935-43, 2007.
C. Huerta, Rivero, E., Montoro, M. A., and Garcia-Rodriguez, L. A., Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study, Aliment Pharmacol Ther, vol. 33, pp. 969-78, 2011.
C. Huerta, Zhao, S. Z., and Rodriguez, L. A. Garcia, Risk of acute liver injury in patients with diabetes, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
C. Huerta and Rodriguez, L. A. Garcia, Risk of clinical blood dyscrasia in a cohort of antibiotic users, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., Risk of irritable bowel syndrome among asthma patients, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
C. Huerta, Johansson, S., Wallander, M. A., and Rodriguez, L. A., Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism, Thromb J, vol. 6, p. 10, 2008.
C. Huerta, Rodriguez, L. A. Garcia, Moller, C. S., and Arellano, F. M., The risk of obstructive airways disease in a glaucoma population, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., Users of oral steroids are at a reduced risk of developing irritable bowel syndrome, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
[Page last reviewed 4 October 2019]